As of Jun 24
| -2.07 / -6.18%|
The 10 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 46.50, with a high estimate of 54.00 and a low estimate of 35.00. The median estimate represents a +47.95% increase from the last price of 31.43.
The current consensus among 10 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.